Back to Search
Start Over
Corrigendum: Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.
- Source :
- Frontiers in Endocrinology; 5/25/2021, Vol. 11, p1-2, 2p
- Publication Year :
- 2021
-
Abstract
- Burosumab, fibroblast growth factor 23, osteomalacia, rickets, vitamin D, X-linked hypophosphatemia Keywords: Burosumab; fibroblast growth factor 23; osteomalacia; rickets; vitamin D; X-linked hypophosphatemia EN Burosumab fibroblast growth factor 23 osteomalacia rickets vitamin D X-linked hypophosphatemia 1 2 2 05/27/21 20210525 NES 210525 There is an error in the Conflict of Interest statement. JV has received conference support and consultancy fees from Alexion, Bellco, Ferring, Medtronic, and Kyowa Kirin. [Extracted from the article]
- Subjects :
- HYPOPHOSPHATEMIA
FIBROBLAST growth factors
RICKETS
Subjects
Details
- Language :
- English
- ISSN :
- 16642392
- Volume :
- 11
- Database :
- Complementary Index
- Journal :
- Frontiers in Endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- 150490122
- Full Text :
- https://doi.org/10.3389/fendo.2021.686401